Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 13,082 |
|
|||||
| News | - | ||||||
| Day High | 2.6002 | Low High |
|||||
| Day Low | 2.5456 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| MyMD Pharmaceuticals Inc | MYMD | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.02 | -0.78% | 2.56 | 11:45:56 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.56 | 2.5456 | 2.6002 | 2.58 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 85 | 13,082 | $ 2.57 | $ 33,649 | - | 2.00 - 70.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:45:53 | 1 | $ 2.5501 | USD |
MyMD Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 5.44M | 2.09M | - | 0 | -8.22M | -3.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
MyMD Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MYMD Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.21 | 2.69 | 2.00 | 2.33 | 59,453 | 0.35 | 15.84% |
| 1 Month | 2.47 | 3.50 | 2.00 | 2.61 | 648,531 | 0.09 | 3.64% |
| 3 Months | 5.10 | 5.289 | 2.00 | 3.47 | 509,511 | -2.54 | -49.80% |
| 6 Months | 12.705 | 14.727 | 2.00 | 6.76 | 991,792 | -10.15 | -79.85% |
| 1 Year | 52.80 | 70.50 | 2.00 | 18.76 | 825,933 | -50.24 | -95.15% |
| 3 Years | 133.50 | 298.50 | 2.00 | 53.07 | 423,499 | -130.94 | -98.08% |
| 5 Years | 162.90 | 298.50 | 2.00 | 57.51 | 442,107 | -160.34 | -98.43% |
MyMD Pharmaceuticals Description
| MyMD Pharmaceuticals Inc is a clinical-stage pharmaceutical company committed to extending a healthy lifespan. It is developing and commercializing two therapeutic platforms. MyMD-1 is a small molecule that regulates the immunometabolic system to treat autoimmune diseases, including multiple sclerosis, diabetes, rheumatoid arthritis, and inflammatory bowel disease. It is being developed to treat age-related illnesses such as frailty and sarcopenia. |
